TISSUE REGENIX HOLDINGS LIMITED
Research and experimental development on biotechnology
TISSUE REGENIX HOLDINGS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Unit 3, Phoenix Court Lotherton Way Garforth Leeds LS25 2GY England
Full company profile for TISSUE REGENIX HOLDINGS LIMITED (10718340), an active life sciences and medical technology company based in Leeds, England. Incorporated 10 Apr 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Cash in Bank
N/A
Net Assets
£20.79M
Total Liabilities
£27.98M
Turnover
N/A
Employees
N/A
Debt Ratio
57%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 5 funding rounds
Sign up to view complete fundraising history
Investors (1)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Jan 2015 | IPO |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Jonathan Martin Glenn | Director | British | United Kingdom | 1 Apr 2020 | Active |
| Kirsten Mary Lund | Secretary | Unknown | Unknown | 20 Dec 2019 | Active |
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Tissue Regenix Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 20 Apr 2026 | Confirmation Statement | Confirmation statement made on 9 Apr 2026 with no updates | |
| 5 Jan 2026 | Mortgage | Mortgage Create With Deed With Charge Number Charge Creation Date | |
| 3 Nov 2025 | Officers | Termination of Daniel Ray Lee as director on 15 Oct 2025 | |
| 3 Nov 2025 | Officers | Appointment of Miss Kirsten Mary Lund as director on 16 Oct 2025 | |
| 11 Sept 2025 | Officers | Termination of Jonathan Martin Glenn as director on 5 Sept 2025 |
Confirmation statement made on 9 Apr 2026 with no updates
Mortgage Create With Deed With Charge Number Charge Creation Date
Termination of Daniel Ray Lee as director on 15 Oct 2025
Appointment of Miss Kirsten Mary Lund as director on 16 Oct 2025
Termination of Jonathan Martin Glenn as director on 5 Sept 2025
Recent Activity
Latest Activity
Confirmation statement made on 9 Apr 2026 with no updates
4 weeks ago on 20 Apr 2026
Mortgage Create With Deed With Charge Number Charge Creation Date
4 months ago on 5 Jan 2026
Termination of Daniel Ray Lee as director on 15 Oct 2025
6 months ago on 3 Nov 2025
Appointment of Miss Kirsten Mary Lund as director on 16 Oct 2025
6 months ago on 3 Nov 2025
Termination of Jonathan Martin Glenn as director on 5 Sept 2025
8 months ago on 11 Sept 2025